Clinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment (vol 60, pg 23, 2023)

Terzi, MuratHelvaci, Elif MerveSen, SedatBoz, CavitCilingir, VedatAkcali, AylinBeckmann, Yesim2024-10-292024-10-2920231300-06671309-4866https://doi.org/10.29399/npa.28499https://hdl.handle.net/20.500.11776/14631[Abstract Not Available]en10.29399/npa.28499info:eu-repo/semantics/openAccessClinical and Demographic Characteristics and Two-Year Efficacy and Safety Data of 508 Multiple Sclerosis Patients with Fingolimod Treatment (vol 60, pg 23, 2023)Correction602190190Q4WOS:0010216421000172-s2.0-8516425514637287556Q3